| Passive | Active | Tissue sealants |
---|---|---|---|
Types | Oxidised cellulose (regenerated) Collagens Powders Gelatin sponges Polysaccharide spheres | Flowables (thrombin and gelatin) Fibrin sealants Advanced patches (with fibrin sealants or polyethylene glycol) | Fibrin based Synthetic (i.e. cyanoacrylates or polyethylene glycol) Semi-synthetic (i.e. glutaraldehyde–albumin) |
Mode of action | Contact activation and platelet aggregation    Relies on the patient’s ability to generate clotting factors | Functions independently of the patient’s ability to generate clotting factors | Functions independently of the patient’s ability to generate clotting factors |
Bleeding range | Mild (capillary oozing) to moderate bleeding | Broad range of active bleeding | Pre-emptive for anticipated bleeding |
Patient factors | Intact coagulation    Limited effect in heparinised and/or anticoagulated treated patients | Compromised coagulation    Effective in heparinised and/or anticoagulated treated patients | Compromised coagulation    Effective in heparinised and/or anticoagulated treated patients |